text
"['\n2. 연결재무제표\n반 \xa0 \xa0 기 \xa0 \xa0 연 \xa0 \xa0 결 \xa0 \xa0 재 \xa0 \xa0 무 \xa0 \xa0 상 \xa0 \xa0 태 \xa0 \xa0 표\n\xa0제 75(당) 반기말 : \xa02023년 06월 30일 현재\n\xa0제 74(전) 기말 \xa0 \xa0: \xa02022년 12월 31일 현재\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 목\n주 \xa0석\n제 75(당) 반기말\n제 74(전) 기말\n자 \xa0 \xa0 \xa0 \xa0 산\n\xa0I. 현금 및 상각후원가 측정 예치금\n6,7\n3,463,077,264,081\n4,767,270,088,559\n\xa0 \xa01. 현금 및 현금성자산\n2,192,952,391,344\n2,902,135,448,284\n\xa0 \xa02. 상각후원가 측정 예치금\n1,270,124,872,737\n-\n\xa0 \xa03. 예치금\n-\n1,865,134,640,275\n\xa0II. 당기손익-공정가치 측정 금융자산\n5,6,8\n51,359,814,284,564\n-\n\xa0III. 당기손익인식유가증권\n5,6,8\n-\n30,982,860,011,448\n\xa0IV. 기타포괄손익-공정가치 측정 유가증권\n5,6,9\n41,571,365,832,707\n-\n\xa0V. 매도가능유가증권\n5,6,9\n-\n42,903,393,854,753\n\xa0VI. 상각후원가 측정 유가증권\n5,6,10\n11,745,170,521,886\n-\n\xa0VII. 만기보유유가증권\n5,6,10\n-\n31,896,062,013,243\n\xa0VIII. 기타포괄손익-공정가치 측정 대출채권\n5,6,9\n1,572,014,172,260\n-\n\xa0IX. 상각후원가 측정 대출채권\n5,6,14\n23,151,305,162,159\n-\n\xa0X. 대출채권\n5,6,14\n-\n25,960,034,438,817\n\xa0XI. 파생상품자산\n5,6,16\n533,318,452,007\n1,007,942,283,352\n\xa0XII. 보험계약자산\n828,218,588\n10,442,952,141\n\xa0XIII. 재보험계약자산\n823,761,039,680\n793,594,342,573\n\xa0XIV. 관계기업 및 공동기업투자\n13\n499,210,572,642\n537,516,485,613\n\xa0XV. 유형자산\n18\n1,618,347,204,292\n1,633,756,720,821\n\xa0XVI. 투자부동산\n18\n2,724,189,434,842\n2,701,400,823,979\n\xa0XVII. 무형자산\n18\n606,113,133,833\n325,546,766,430\n\xa0XVIII. 순확정급여자산\n26\n64,395,735,841\n35,721,694,704\n\xa0XIX. 사용권자산\n18,19\n198,158,555,090\n170,377,512,222\n\xa0XX. 당기법인세자산\n114,106,727,466\n236,492,112,973\n\xa0XXI. 이연법인세자산\n18,471,015,355\n8,450,078,662\n\xa0XXII. 기타금융자산\n5,6,15\n2,748,391,826,564\n2,168,346,937,914\n\xa0XXIII. 기타자산\n20\n236,923,928,466\n122,833,484,284\n자 \xa0 \xa0산 \xa0 \xa0총 \xa0 \xa0계\n143,048,963,082,323\n146,262,042,602,488\n부 \xa0 \xa0 \xa0 \xa0 채\n\xa0I. 보험계약부채\n21\n98,099,485,767,116\n96,981,079,483,120\n\xa0II. 재보험계약부채\n21\n28,141,921,320\n42,215,746,783\n\xa0III. 투자계약부채\n5,6,22\n7,907,616,639,409\n8,187,640,447,941\n\xa0IV. 계약자지분조정\n23\n17,664,022,896\n17,888,454,610\n\xa0V. 당기손익-공정가치 측정 금융부채\n5,6,24\n2,371,732,252,567\n-\n\xa0VI. 당기손익인식금융부채\n5,6,24\n-\n2,769,309,754,587\n\xa0VII. 차입부채 및 사채\n5,6,25\n10,294,830,792,391\n9,848,429,543,178\n\xa0VIII. 파생상품부채\n5,6,16\n2,453,382,041,363\n2,306,919,297,870\n\xa0IX. 순확정급여부채\n26\n297,055,957,863\n256,223,856,643\n\xa0X. 당기법인세부채\n11,948,100,149\n128,813,603,881\n\xa0XI. 이연법인세부채\n1,420,377,409,831\n2,464,278,476,340\n\xa0XII. 충당부채\n27\n90,706,831,575\n125,570,590,132\n\xa0XIII. 기타금융부채\n5,6,19,28\n3,811,186,733,303\n3,041,294,914,970\n\xa0XIV. 기타부채\n29\n96,970,705,502\n73,145,048,782\n부 \xa0 \xa0채 \xa0 \xa0총 \xa0 \xa0계\n126,901,099,175,285\n126,242,809,218,837\n자 \xa0 \xa0 \xa0 \xa0 본\n\xa0 지배기업의 소유주에게 귀속되는 자본\n\xa0I. 자본금\n30\n4,342,650,000,000\n4,342,650,000,000\n\xa0II. 기타불입자본\n30\n(307,471,455,000)\n(105,190,382,703)\n\xa0III. 신종자본증권\n31\n498,343,801,550\n1,558,370,079,138\n\xa0IV. 기타자본구성요소\n32\n1,748,965,444,869\n3,702,141,398,940\n\xa0V. 이익잉여금\n33\n7,368,474,909,123\n8,206,790,516,140\n\xa0 비지배지분\n2,496,901,206,496\n2,314,471,772,136\n자 \xa0 \xa0본 \xa0 \xa0총 \xa0 \xa0계\n16,147,863,907,038\n20,019,233,383,651\n부 \xa0 \xa0채 \xa0 \xa0와 \xa0 \xa0자 \xa0 \xa0본 \xa0 \xa0총 \xa0 \xa0계\n143,048,963,082,323\n146,262,042,602,488\n별첨 주석은 본 반기연결재무제표의 일부입니다.\n\xa0반 \xa0 \xa0기 \xa0 \xa0연 \xa0 \xa0결 \xa0 \xa0포 \xa0 \xa0괄 \xa0 \xa0손 \xa0 \xa0익 \xa0 \xa0계 \xa0 \xa0산 \xa0 \xa0서\n제 75(당) 반기 : 2023년 1월 1일부터 2023년 06월 30일까지\n제 74(전) 반기 : 2022년 1월 1일부터 2022년 06월 30일까지\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0목\n주 석\n제 75(당) 반기\n제 74(전) 반기\n3 개 월\n\xa0누 \xa0 적\n3 개 월\n누 \xa0 적\n\xa0I. \xa0보험영업손익\n21\n288,832,299,955\n547,314,283,768\n259,653,556,164\n677,749,777,740\n\xa0 1. \xa0보험손익\n440,528,900,665\n706,208,970,759\n428,875,126,202\n884,996,337,866\n\xa0 \xa0 1) 보험영업수익\n2,309,974,244,217\n4,606,472,727,584\n2,204,084,693,742\n4,361,339,931,062\n\xa0 \xa0 2) 보험서비스비용\n1,869,445,343,552\n3,900,263,756,825\n1,775,209,567,540\n3,476,343,593,196\n\xa0 2. \xa0출재보험손익\n(4,054,592,669)\n(11,252,678,950)\n(37,449,370,015)\n(75,474,360,103)\n\xa0 \xa0 1) 출재보험수익\n167,029,156,010\n336,580,729,095\n163,329,825,424\n306,279,788,997\n\xa0 \xa0 2) 출재보험비용\n171,083,748,679\n347,833,408,045\n200,779,195,439\n381,754,149,100\n\xa0 3. \xa0기타사업비용\n147,642,008,041\n147,642,008,041\n131,772,200,023\n131,772,200,023\n\xa0II. \xa0투자영업손익\n21\n626,391,423,185\n2,784,893,622,654\n118,342,631,756\n298,745,407,942\n\xa0 1. \xa0투자영업수익\n2,448,350,483,513\n7,394,185,180,601\n3,330,228,169,045\n5,987,701,838,589\n\xa0 \xa0 1) 이자수익\n933,876,870,589\n1,822,838,673,496\n802,497,094,104\n1,595,937,776,770\n\xa0 \xa0 2) 배당수익\n60,288,506,393\n132,665,691,056\n216,396,682,458\n467,081,008,407\n\xa0 \xa0 3) 임대료수익\n44,202,856,299\n79,119,272,903\n37,783,903,255\n74,965,712,187\n\xa0 \xa0 4) 당기손익-공정가치 측정 금융자산 관련이익\n399,072,888,751\n1,982,660,801,433\n-\n-\n\xa0 \xa0 5) 당기손익인식유가증권 평가 및 처분이익\n-\n-\n280,503,733,427\n607,090,826,515\n\xa0 \xa0 6) 기타포괄손익-공정가치 측정 금융자산 관련이익\n18,309,883,795\n22,257,333,549\n-\n-\n\xa0 \xa0 7) 매도가능유가증권 평가 및 처분이익\n-\n-\n191,896,026,208\n325,004,610,336\n\xa0 \xa0 8) 상각후원가 측정 금융자산 관련이익\n1,100,446,871\n2,262,008,234\n-\n-\n\xa0 \xa0 9) 대출채권 및 수취채권 평가 및 처분이익\n-\n-\n570,090,926\n570,090,926\n\xa0 \xa0 10) 외환거래 및 환산이익\n264,253,822,482\n1,259,791,127,605\n1,224,191,419,446\n1,742,268,525,486\n\xa0 \xa0 11) 파생상품평가 및 거래이익\n393,567,241,504\n1,493,648,638,483\n510,176,913,661\n958,901,260,114\n\xa0 \xa0 12) 기타투자수익\n333,677,966,829\n598,941,633,842\n66,212,305,560\n215,882,027,848\n\xa0 2. \xa0투자영업비용\n1,821,959,060,328\n4,609,291,557,947\n3,211,885,537,289\n5,688,956,430,647\n\xa0 \xa0 1) 이자비용\n111,066,944,931\n225,922,239,109\n(9,906,006,936)\n96,828,870,432\n\xa0 \xa0 2) 재산관리비\n40,127,811,471\n52,992,182,695\n39,870,041,704\n45,763,639,852\n\xa0 \xa0 3) 당기손익-공정가치 측정 금융자산 관련손실\n350,760,486,587\n836,806,222,718\n-\n-\n\xa0 \xa0 4) 당기손익인식유가증권 평가 및 처분손실\n-\n-\n1,128,743,221,401\n2,135,106,921,248\n\xa0 \xa0 5) 기타포괄손익-공정가치 측정 금융자산 관련손실\n12,576,673,396\n18,314,927,804\n-\n-\n\xa0 \xa0 6) 매도가능유가증권 평가 및 처분손실\n-\n-\n96,186,626,445\n138,027,273,675\n\xa0 \xa0 7) 상각후원가 측정 금융자산 관련손실\n17,028,665,443\n45,191,144,590\n-\n-\n\xa0 \xa0 8) 대출채권 및 수취채권 평가 및 처분손실\n-\n-\n(4,382,610,885)\n6,513,755,751\n\xa0 \xa0 9) 외환거래 및 환산손실\n136,362,986,811\n403,297,196,636\n135,445,392,877\n265,712,210,812\n\xa0 \xa0 10) 파생상품평가 및 거래손실\n660,236,787,724\n2,280,803,078,443\n1,550,091,552,518\n2,581,842,821,650\n\xa0 \xa0 11) 기타투자비용\n493,798,703,965\n745,964,565,952\n275,837,320,165\n419,160,937,227\n\xa0III. \xa0보험금융손익\n21\n(756,667,614,465)\n(2,411,768,225,303)\n373,893,219,216\n632,074,130,964\n\xa0 1. \xa0보험금융손익\n(758,567,397,686)\n(2,416,452,540,015)\n368,213,056,613\n622,784,791,072\n\xa0 2. \xa0재보험금융손익\n1,899,783,221\n4,684,314,712\n5,680,162,603\n9,289,339,892\n\xa0IV. \xa0영업이익\n158,556,108,675\n920,439,681,119\n751,889,407,136\n1,608,569,316,646\n\xa0V. \xa0영업외수익\n34\n151,910,266,804\n16,982,611,665\n149,610,541,794\n51,257,487,201\n\xa0VI. \xa0영업외비용\n34\n9,562,449,516\n26,255,677,456\n38,176,470,928\n77,717,601,470\n\xa0VII. \xa0법인세비용차감전순이익\n300,903,925,963\n911,166,615,328\n863,323,478,002\n1,582,109,202,377\n\xa0VIII. \xa0법인세비용\n35\n60,606,472,539\n207,385,360,161\n237,100,486,661\n417,760,801,343\n\xa0IX. \xa0반기순이익\n240,297,453,424\n703,781,255,167\n626,222,991,341\n1,164,348,401,034\n\xa0X. \xa0법인세비용차감후 기타포괄손익\n923,956,937,302\n105,846,059,559\n1,229,134,045,765\n4,110,897,937,431\n\xa0 1. \xa0후속적으로 당기손익으로 재분류되지 않는 항목\n354,854,527,941\n305,956,486,098\n14,337,499,398\n(926,154,079)\n\xa0 \xa0 1) 기타포괄손익-공정가치 측정 지분증권 평가손익\n287,008,140,852\n287,008,140,852\n-\n-\n\xa0 \xa0 2) 유형자산재평가손익\n70,616,837,251\n21,400,292,753\n14,337,499,398\n3,233,146,266\n\xa0 \xa0 3) 확정급여채무 재측정요소\n(2,770,450,162)\n(2,451,947,507)\n-\n(4,159,300,345)\n\xa0 2. \xa0후속적으로 당기손익으로 재분류되는 항목\n569,102,409,361\n(200,110,426,539)\n1,214,796,546,367\n4,111,824,091,510\n\xa0 \xa0 1) 기타포괄손익-공정가치 측정 채무증권 평가손익\n(1,497,945,194,123)\n108,938,090,330\n-\n-\n\xa0 \xa0 2) 매도가능금융자산평가손익\n-\n-\n(2,279,366,147,890)\n(3,731,629,014,234)\n\xa0 \xa0 3) 만기보유금융자산평가손익\n-\n-\n(117,736,221,822)\n(117,736,221,822)\n\xa0 \xa0 4) 관계기업의 기타포괄손익지분\n5,376,642,580\n9,725,402,025\n(7,423,355,556)\n(17,604,588,037)\n\xa0 \xa0 5) 보험계약자산(부채)순금융손익\n2,227,199,513,469\n(325,354,640,374)\n3,943,230,087,467\n8,490,793,478,237\n\xa0 \xa0 6) 재보험계약자산(부채)순금융손익\n9,258,239,452\n18,195,191,482\n629,700,489\n(1,556,278,852)\n\xa0 \xa0 7) 위험회피목적파생상품평가손익\n(192,999,551,201)\n(45,138,780,578)\n(368,749,551,171)\n(560,099,546,176)\n\xa0 \xa0 8) 해외사업환산손익\n18,212,759,184\n33,524,310,576\n44,212,034,850\n49,656,262,394\n\xa0XI. \xa0반기총포괄이익\n1,164,254,390,726\n809,627,314,726\n1,855,357,037,106\n5,275,246,338,465\n\xa0XII. \xa0반기순이익의 귀속\n240,297,453,424\n703,781,255,167\n626,222,991,341\n1,164,348,401,034\n\xa0 1. \xa0지배기업의 소유주\n202,422,095,317\n624,972,277,457\n556,222,615,290\n1,035,191,471,770\n\xa0 2. \xa0비지배지분\n37,875,358,107\n78,808,977,710\n70,000,376,051\n129,156,929,264\n\xa0XIII. \xa0반기총포괄이익의 귀속\n1,164,254,390,726\n809,627,314,726\n1,855,357,037,106\n5,275,246,338,465\n\xa0 1. \xa0지배기업의 소유주\n1,094,730,169,458\n699,169,473,855\n1,776,660,828,061\n5,084,634,999,067\n\xa0 2. \xa0비지배지분\n69,524,221,268\n110,457,840,871\n78,696,209,045\n190,611,339,398\n\xa0XIV. \xa0주당이익\n\xa0 1. 기본 및 희석 주당이익\n354\n886\n773\n1,489\n별첨 주석은 본 반기연결재무제표의 일부입니다.\n반 \xa0 \xa0기 \xa0 \xa0연 \xa0 \xa0결 \xa0 \xa0자 \xa0 \xa0본 \xa0 \xa0변 \xa0 \xa0동 \xa0 \xa0표\n제 75(당) 반기 : 2023년 1월 1일부터 2023년 06월 30일까지\n제 74(전) 반기 : 2022년 1월 1일부터 2022년 06월 30일까지\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 목\n자 \xa0본 \xa0금\n기타불입자본\n신종자본증권\n기타자본구성요소\n이익잉여금\n지배기업의소유주 귀속\n비지배지분\n총 \xa0 \xa0계\n2022년 1월 1일(전기초)\n4,342,650,000,000\n(452,754,777,309)\n2,056,343,999,076\n244,554,628,930\n5,083,054,481,257\n11,273,848,331,954\n2,145,732,682,706\n13,419,581,014,660\n기업회계기준서 제1117호 최초 적용에 따른 조정\n-\n-\n-\n33,874,012,725\n1,911,668,127,366\n1,945,542,140,091\n180,084,554,644\n2,125,626,694,735\n2022년 1월 1일(전기초-조정후)\n4,342,650,000,000\n(452,754,777,309)\n2,056,343,999,076\n278,428,641,655\n6,994,722,608,623\n13,219,390,472,045\n2,325,817,237,350\n15,545,207,709,395\nI. 반기총포괄손익\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 1. 반기순이익\n-\n-\n-\n-\n1,035,191,471,770\n1,035,191,471,770\n129,156,929,264\n1,164,348,401,034\n\xa0 2. 재평가잉여금의 대체\n-\n-\n-\n(14,120,304,514)\n14,120,304,514\n-\n-\n-\n\xa0 3. 유형자산재평가손익\n-\n-\n-\n3,233,146,266\n-\n3,233,146,266\n-\n3,233,146,266\n\xa0 4. 확정급여제도의 재측정요소\n-\n-\n-\n(4,159,300,345)\n-\n(4,159,300,345)\n-\n(4,159,300,345)\n\xa0 5. 매도가능금융자산평가손익\n-\n-\n-\n(3,077,655,965,783)\n-\n(3,077,655,965,783)\n(653,973,048,451)\n(3,731,629,014,234)\n\xa0 6. 만기보유금융자산평가손익\n-\n-\n-\n(117,736,221,822)\n-\n(117,736,221,822)\n-\n(117,736,221,822)\n\xa0 7. 관계기업의 기타포괄손익지분\n-\n-\n-\n(8,491,155,463)\n-\n(8,491,155,463)\n(9,113,432,574)\n(17,604,588,037)\n\xa0 8. 보험계약자산(부채)순금융손익\n-\n-\n-\n7,708,843,450,712\n-\n7,708,843,450,712\n781,950,027,525\n8,490,793,478,237\n\xa0 9. 재보험계약자산(부채)순금융손익\n-\n-\n-\n(894,168,308)\n-\n(894,168,308)\n(662,110,544)\n(1,556,278,852)\n\xa0 10. 위험회피목적파생상품평가손익\n-\n-\n-\n(500,209,659,590)\n-\n(500,209,659,590)\n(59,889,886,586)\n(560,099,546,176)\n\xa0 11. 해외사업환산손익\n-\n-\n-\n46,513,401,630\n-\n46,513,401,630\n3,142,860,764\n49,656,262,394\nII. 자본에 직접 인식된 주주와의 거래\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\u3000\n\xa0 1. 연차배당\n-\n-\n-\n-\n-\n-\n(24,050,643,200)\n(24,050,643,200)\n\xa0 2. 신종자본증권의 배당\n-\n-\n-\n-\n(45,556,924,844)\n(45,556,924,844)\n(6,477,500,000)\n(52,034,424,844)\n\xa0 3. 신종자본증권의 발행\n-\n-\n-\n-\n-\n-\n35,000,000,000\n35,000,000,000\n\xa0 4. 신종자본증권의 상환\n-\n(2,026,080,063)\n(497,973,919,937)\n-\n\u3000\n(500,000,000,000)\n(30,000,000,000)\n(530,000,000,000)\n\xa0 5. 주식기준보상\n-\n3,558,017,150\n-\n-\n-\n3,558,017,150\n1,427,526,717\n4,985,543,867\nIII. 비지배지분의 증감\r\n-\n-\n-\n-\n-\n-\n745,000,000\n745,000,000\n2022년 6월 30일(전반기말)\n4,342,650,000,000\n(451,222,840,222)\n1,558,370,079,139\n4,313,751,864,438\n7,998,477,460,063\n17,762,026,563,418\n2,493,072,960,265\n20,255,099,523,683\n2023년 1월 1일(당기초)\n4,342,650,000,000\n(105,190,382,703)\n1,558,370,079,139\n3,702,141,398,940\n8,206,790,516,140\n17,704,761,611,516\n2,314,471,772,136\n20,019,233,383,651\n기업회계기준서 제1109호 최초 적용에 따른 조정\n-\n-\n-\n(2,019,778,388,430)\n(1,442,245,026,586)\n(3,462,023,415,016)\n(59,287,903,028)\n(3,521,311,318,044)\n2023년 1월 1일(당기초-조정후)\n4,342,650,000,000\n(105,190,382,703)\n1,558,370,079,139\n1,682,363,010,510\n6,764,545,489,554\n14,242,738,196,500\n2,255,183,869,108\n16,497,922,065,608\nI. 반기총포괄손익\n\xa0 1. 반기순이익\n-\n-\n-\n-\n624,972,277,457\n624,972,277,457\n78,808,977,710\n703,781,255,167\n\xa0 2. 재평가잉여금의 대체\n-\n-\n-\n(7,594,762,039)\n7,594,762,039\n-\n-\n-\n\xa0 3. 유형자산재평가손익\n-\n-\n-\n21,400,292,753\n-\n21,400,292,753\n-\n21,400,292,753\n\xa0 4. 확정급여제도의 재측정요소\n-\n-\n-\n(2,456,423,622)\n-\n(2,456,423,622)\n4,476,115\n(2,451,947,507)\n\xa0 5. 기타포괄손익-공정가치 금융자산 평가손익\n-\n-\n-\n330,447,428,675\n-\n330,447,428,675\n65,498,802,507\n395,946,231,182\n\xa0 6. 관계기업의 기타포괄손익지분\n-\n-\n-\n7,097,084,966\n-\n7,097,084,966\n2,628,317,059\n9,725,402,025\n\xa0 7. 보험계약자산(부채)순금융손익\n-\n-\n-\n(284,560,582,115)\n-\n(284,560,582,115)\n(40,794,058,259)\n(325,354,640,374)\n\xa0 8. 재보험계약자산(부채)순금융손익\n-\n-\n-\n17,538,172,595\n-\n17,538,172,595\n657,018,887\n18,195,191,482\n\xa0 9. 위험회피목적파생상품평가손익\n-\n-\n-\n(46,695,016,251)\n-\n(46,695,016,251)\n1,556,235,673\n(45,138,780,578)\n\xa0 10. 해외사업환산손익\n-\n-\n-\n31,426,239,397\n-\n31,426,239,397\n2,098,071,179\n33,524,310,576\nII. 자본에 직접 인식된 주주와의 거래\n\xa0 1. 연차배당\n-\n-\n-\n-\n-\n-\n(526,712,440)\n(526,712,440)\n\xa0 2. 신종자본증권의 배당\n-\n-\n-\n-\n(28,637,619,927)\n(28,637,619,927)\n(9,115,000,000)\n(37,752,619,927)\n\xa0 3. 신종자본증권의 상환\n-\n(204,800,927,134)\n(1,060,026,277,589)\n-\n-\n(1,264,827,204,723)\n-\n(1,264,827,204,723)\n\xa0 4. 주식기준보상\n-\n4,195,234,960\n-\n-\n-\n4,195,234,960\n797,968,233\n4,993,203,193\nIII. 비지배지분의 증감\n-\n(1,675,380,123)\n-\n-\n-\n(1,675,380,123)\n140,103,240,724\n138,427,860,601\n2023년 6월 30일(당반기말)\n4,342,650,000,000\n(307,471,455,000)\n498,343,801,550\n1,748,965,444,869\n7,368,474,909,123\n13,650,962,700,542\n2,496,901,206,496\n16,147,863,907,038\n별첨 주석은 본 반기연결재무제표의 일부입니다.\n반 \xa0 \xa0기 \xa0 \xa0연 \xa0 \xa0결 \xa0 \xa0현 \xa0 \xa0금 \xa0 \xa0흐 \xa0 \xa0름 \xa0 \xa0표\n제 75 기(당) 반기 : 2023년 1월 1일부터 2023년 06월 30일까지\n제 74 기(전) 반기 : 2022년 1월 1일부터 2022년 06월 30일까지\n한화생명보험주식회사와 그 종속기업\n(단위 : 원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0 \xa0목\n주 석\n제 75(당) 반기\n제 74(전) 반기\nI. 영업활동으로 인한 현금흐름\n\u3000\n(441,757,411,102)\n\u3000\n1,563,569,901,141\n\xa0 1. 반기순이익\n703,781,255,167\n\u3000\n1,164,348,401,034\n\u3000\n\xa0 2. 수익ㆍ비용의 조정\n38\n(932,444,960,090)\n\u3000\n(1,185,174,435,732)\n\u3000\n\xa0 3. 영업활동으로 인한 자산ㆍ부채의 변동\n38\n(2,182,025,255,661)\n\u3000\n(123,539,774,758)\n\u3000\n\xa0 4. 이자의 수취\n1,699,535,210,018\n\u3000\n1,506,719,245,658\n\u3000\n\xa0 5. 이자의 지급\n(210,279,121,425)\n\u3000\n(87,078,548,296)\n\u3000\n\xa0 6. 배당금의 수취\n461,205,453,503\n\u3000\n467,053,836,828\n\u3000\n\xa0 7. 법인세환급(부담)액\n18,470,007,386\n\u3000\n(178,758,823,593)\n\u3000\nII. 투자활동으로 인한 현금흐름\n660,950,939,141\n\u3000\n(1,483,735,727,800)\n\xa0 1. 당기손익-공정가치 측정 금융상품의 처분\n19,410,168,266,074\n-\n\u3000\n\xa0 2. 기타포괄손익-공정가치 측정 금융상품의 처분\n1,385,552,102,174\n-\n\u3000\n\xa0 3. 상각후원가 측정 금융상품의 처분\n188,244,716,259\n-\n\u3000\n\xa0 4. 매도가능금융자산의 처분\n-\n6,256,387,884,827\n\u3000\n\xa0 5. 만기보유금융자산의 상환\n-\n10,597,139,798\n\u3000\n\xa0 6. 투자부동산 및 유형자산의 처분\n29,598,342,083\n146,770,020,309\n\u3000\n\xa0 7. 무형자산의 처분\n393,988,968\n5,943,348,671\n\u3000\n\xa0 8. 관계기업투자의 처분\n102,341,253,236\n22,011,146,823\n\u3000\n\xa0 9. 관계기업투자의 배당\n2,805,069,908\n3,988,049,433\n\u3000\n\xa0 10. 예치보증금의 감소\n3,001,774,511\n13,308,201,647\n\u3000\n\xa0 11. 금융리스채권의 감소\n-\n316,537,254\n\u3000\n\xa0 12. 선급금의 감소\n-\n610,880,968\n\u3000\n\xa0 13. 연결범위변동으로 인한 현금흐름\n(332,429,853,501)\n-\n\u3000\n\xa0 14. 위험회피목적 파생상품의 정산\n(211,786,536,507)\n(295,935,423,740)\n\u3000\n\xa0 15. 당기손익-공정가치 측정 금융상품의 취득\n(11,975,636,665,196)\n-\n\u3000\n\xa0 16. 기타포괄손익-공정가치 측정 금융상품의 취득\n(7,773,217,167,461)\n-\n\u3000\n\xa0 17. 상각후원가 측정 금융상품의 취득\n(23,081,715,446)\n-\n\u3000\n\xa0 18. 매도가능금융자산의 취득\n-\n(4,667,439,234,678)\n\u3000\n\xa0 19. 만기보유금융자산의 취득\n-\n(2,824,922,331,015)\n\u3000\n\xa0 20. 투자부동산 및 유형자산의 취득\n(47,690,459,889)\n(38,386,970,024)\n\u3000\n\xa0 21. 무형자산의 취득\n(32,101,786,443)\n(18,150,617,230)\n\u3000\n\xa0 22. 관계기업투자의 취득\n(64,643,503,819)\n(60,566,773,598)\n\u3000\n\xa0 23. 예치보증금의 증가\n-\n(29,046,860,243)\n\u3000\n\xa0 24. 금융리스채권의 증가\n(566,885,810)\n-\n\u3000\n\xa0 25. 선급금의 증가\n-\n(9,220,727,002)\n\u3000\nIII. 재무활동으로 인한 현금흐름\n(932,061,540,418)\n\u3000\n(69,927,814,529)\n\xa0 1. 비지배지분의 증가\n110,384,035,000\n35,745,000,000\n\u3000\n\xa0 2. 비지배지분의 감소\n(12,464,806,190)\n(60,528,143,200)\n\u3000\n\xa0 3. 임대보증금의 증가\n-\n17,390,847,267\n\u3000\n\xa0 4. 임대보증금의 감소\n(3,464,993,696)\n(15,118,637,147)\n\u3000\n\xa0 5. 신종자본증권의 상환\n(1,327,600,000,000)\n(500,000,000,000)\n\u3000\n\xa0 6. 신종자본증권의 배당\n(40,423,600,000)\n(49,798,167,123)\n\u3000\n\xa0 7. 차입부채의 증가\n335,516,235,309\n2,886,617,071,076\n\u3000\n\xa0 8. 차입부채의 감소\n(147,461,196,157)\n(2,452,137,786,937)\n\u3000\n\xa0 9. 환매조건부채권매도의 순증감\n210,418,649,051\n33,292,715,440\n\u3000\n\xa0 10. 기타금융부채의 변동\n(43,674,607,948)\n65,438,391,041\n\u3000\n\xa0 11. 리스부채의 감소\n(13,291,255,787)\n(30,829,104,946)\n\u3000\nIV. 현금및현금성자산의 순증가(감소)(Ⅰ+Ⅱ+Ⅲ)\n(712,868,012,379)\n9,906,358,812\nV. 기초 현금및현금성자산\n2,902,135,448,284\n2,044,657,688,947\nVI. 외화표시 현금및현금성자산 환율변동효과\n3,684,955,439\n12,473,438,216\nⅦ. 반기말 현금및현금성자산\n2,192,952,391,344\n2,067,037,485,975\n별첨 주석은 본 반기연결재무제표의 일부입니다.\n']"
